These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 21494268)

  • 1. Overcoming hurdles in developing successful drugs targeting chemokine receptors.
    Schall TJ; Proudfoot AE
    Nat Rev Immunol; 2011 May; 11(5):355-63. PubMed ID: 21494268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical potential of chemokine receptor antagonists.
    Ribeiro S; Horuk R
    Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor antagonists: overcoming developmental hurdles.
    Horuk R
    Nat Rev Drug Discov; 2009 Jan; 8(1):23-33. PubMed ID: 19079127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The attraction of chemokines as a target for specific anti-inflammatory therapy.
    Pease JE; Williams TJ
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S212-21. PubMed ID: 16402107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP; Zwillich SH; Clucas AT; Brown MF
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR1 chemokine receptor antagonist.
    Saeki T; Naya A
    Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine: receptor structure, interactions, and antagonism.
    Allen SJ; Crown SE; Handel TM
    Annu Rev Immunol; 2007; 25():787-820. PubMed ID: 17291188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment for rheumatoid arthritis by chemokine blockade].
    Nanki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):172-80. PubMed ID: 27320932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z; Koch AE; Tak PP
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest update on chemokine receptors as therapeutic targets.
    Lai WY; Mueller A
    Biochem Soc Trans; 2021 Jun; 49(3):1385-1395. PubMed ID: 34060588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine inhibition in inflammatory arthritis.
    Tak PP
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):929-39. PubMed ID: 16980215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
    Russo RC; Garcia CC; Teixeira MM
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):414-27. PubMed ID: 20597027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X; Oppenheim JJ; Howard OM
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines and chemokine receptors in rheumatoid arthritis.
    Szekanecz Z; Kim J; Koch AE
    Semin Immunol; 2003 Feb; 15(1):15-21. PubMed ID: 12495637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ; Oostendorp RL; Tak PP
    Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptors in inflammation: an overview.
    D'Ambrosio D; Panina-Bordignon P; Sinigaglia F
    J Immunol Methods; 2003 Feb; 273(1-2):3-13. PubMed ID: 12535793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cell migration in rheumatoid arthritis.
    Asquith DL; Bryce SA; Nibbs RJ
    Curr Opin Rheumatol; 2015 Mar; 27(2):204-11. PubMed ID: 25603038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1 antagonists in clinical development.
    Pease JE; Horuk R
    Expert Opin Investig Drugs; 2005 Jul; 14(7):785-96. PubMed ID: 16022568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptors: multifaceted therapeutic targets.
    Proudfoot AE
    Nat Rev Immunol; 2002 Feb; 2(2):106-15. PubMed ID: 11910892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor antagonists from discovery to the clinic.
    Horuk R
    Ernst Schering Res Found Workshop; 2004; (44):169-90. PubMed ID: 14579780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.